300896 Stock Overview
Engages in the research and development, production, and transformation of biomedical soft tissue repair materials in China.
| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 6/6 |
| Past Performance | 5/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
No risks detected for 300896 from our risk checks.
Imeik Technology Development Co.,Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥144.96 |
| 52 Week High | CN¥324.71 |
| 52 Week Low | CN¥135.99 |
| Beta | 1.11 |
| 11 Month Change | -15.55% |
| 3 Month Change | -26.79% |
| 1 Year Change | -53.77% |
| 33 Year Change | -60.63% |
| 5 Year Change | n/a |
| Change since IPO | 7.41% |
Recent News & Updates
Shareholder Returns
| 300896 | CN Biotechs | CN Market | |
|---|---|---|---|
| 7D | 2.6% | 2.3% | 1.5% |
| 1Y | -53.8% | -22.6% | -18.8% |
Return vs Industry: 300896 underperformed the CN Biotechs industry which returned -22.6% over the past year.
Return vs Market: 300896 underperformed the CN Market which returned -18.8% over the past year.
Price Volatility
| 300896 volatility | |
|---|---|
| 300896 Average Weekly Movement | 6.1% |
| Biotechs Industry Average Movement | 5.9% |
| Market Average Movement | 5.6% |
| 10% most volatile stocks in CN Market | 8.9% |
| 10% least volatile stocks in CN Market | 3.8% |
Stable Share Price: 300896's share price has been volatile over the past 3 months.
Volatility Over Time: 300896's weekly volatility (6%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2004 | 910 | Yifeng Shi | www.imeik.net/cn/ |
Imeik Technology Development Co.,Ltd. engages in the research and development, production, and transformation of biomedical soft tissue repair materials in China. The company offers aesthetic medicine products, including cross-linked sodium hyaluronate gel with PLLA-b-PEG microsphere, poly facial implant thread, medical sodium hyaluronate-hydroxypropyl methylcellulose gel, sodium hyaluronate composite solution for injection, modified sodium hyaluronate gel for injection, and medical PVA gel ball-sodium hyaluronate-hydroxypropyl methylcellulose gel.
Imeik Technology Development Co.,Ltd. Fundamentals Summary
| 300896 fundamental statistics | |
|---|---|
| Market cap | CN¥43.67b |
| Earnings (TTM) | CN¥2.02b |
| Revenue (TTM) | CN¥3.07b |
21.7x
P/E Ratio14.2x
P/S RatioIs 300896 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 300896 income statement (TTM) | |
|---|---|
| Revenue | CN¥3.07b |
| Cost of Revenue | CN¥158.10m |
| Gross Profit | CN¥2.91b |
| Other Expenses | CN¥892.69m |
| Earnings | CN¥2.02b |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 6.69 |
| Gross Margin | 94.84% |
| Net Profit Margin | 65.74% |
| Debt/Equity Ratio | 0% |
How did 300896 perform over the long term?
See historical performance and comparison